IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 16 holdings | $29.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$10.0M132,00033.6%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$9.2M136,00030.8%
Centene Corp del(CNC)COM15135B101$6.4M147,00021.4%
Caredx Inc(CDNA)COM14167L103$4.2M184,85514.0%
Gilead Sciences Inc(GILD)COM375558103$12.5K197,9160.0%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$11.0K64,8490.0%
Bristol Myers Squibb Co(BMY)COM110122108$10.0K197,9370.0%
Iqvia Hldgs Inc(IQV)COM46266C105$8.7K57,9860.0%
Thermo Fisher Scientific Inc(TMO)COM883556102$8.4K28,9760.0%
Humana Inc(HUM)COM444859102$7.9K31,0000.0%
Merck & Co Inc(MRK)COM58933Y105$6.2K74,0000.0%
Zoetis Inc(ZTS)CL A98978V103$3.8K30,3750.0%
Illumina Inc(ILMN)COM452327109$2.8K9,3160.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$2.7K335,0000.0%
Sientra IncCOM82621J105$2.5K385,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$1.2K75,0000.0%